New York, USA, Nov. 09, 2022 (GLOBE NEWSWIRE) -- The Global Aortic Aneurysm Stent Grafts Market to Exhibit Positive Growth at a CAGR of 5.71% During the Forecast Period (2022–2027) | DelveInsight
The aortic aneurysm stent grafts market is expected to surge due to an increase in the number of patients suffering from aortic aneurysms and an aging population, rising regulatory approvals, and rapid technological development activities. Furthermore, an increase in the prevalence of cardiac diseases and growing awareness of these devices are driving the growth of the aortic aneurysm stent grafts market from 2022 to 2027.
DelveInsight’s Aortic Aneurysm Stent Grafts Market Insights report provides the current and forecast market, forthcoming device innovation, individual leading companies’ market shares, challenges, aortic aneurysm stent grafts market drivers, barriers, and trends, and key aortic aneurysm stent grafts companies in the market.
Key Takeaways from the Aortic Aneurysm Stent Grafts Market Report
- As per DelveInsight estimates, North America is anticipated to dominate the global aortic aneurysm stent grafts market during the forecast period.
- Notable aortic aneurysm stent grafts companies such as Medtronic, Terumo, Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (MicroPort Scientific Corporation), Cook, Cordis, JOTEC GmbH, W. L. Gore & Associates, Inc., Endologix LLC, Lombard Medical, Lifetech Scientific, SB-Kawasumi Laboratories, Inc., Endospan, and several others are currently operating in the aortic aneurysm stent grafts market.
- On May 11, 2021, Endologix LLC announced the launch and first implant of its ALTO® Abdominal Stent Graft in Canada following recent approval from Health Canada.
To read more about the latest highlights related to the aortic aneurysm stent grafts market, get a snapshot of the key highlights entailed in the Global Aortic Aneurysm Stent Grafts Market Report
Aortic Aneurysm Stent Grafts Overview
Aortic aneurysm stent grafts are devices that are placed inside the abdominal or thoracic aorta to help prevent the aneurysm from rupturing. The stent graft is inserted into the aneurysm via a delivery catheter, which is a long, very thin, soft plastic tube.
Endovascular aortic stent grafts have several advantages over open repair methods, including shorter postoperative hospital stays, lower surgical morbidity and mortality rates, and less invasiveness. Aortic graft disadvantages include the need for ongoing imaging surveillance and concerns about the graft’s long-term viability.
Aortic Aneurysm Stent Grafts Market Insights
As per the DelveInsight assessment, North America is expected to account for the largest share of the global aortic aneurysm stent grafts market among all regions. Rising aortic aneurysm cases, technological advancements, and strong financial incentives are expected to aid in the growth of the North American aortic aneurysm stent grafts market between 2022 and 2027.
The increasing regulatory product approvals of innovative devices is another factor driving the growth of the aortic aneurysm stent grafts market. Endologix LLC, for example, announced the launch and first implant of its ALTO® Abdominal Stent Graft in Canada on May 11, 2021, following recent approval from Health Canada.
Moreover, the rising adoption of aortic aneurysm stent grafts in the country would result in rising demand for treatments that use aortic aneurysm stent grafts, creating a favorable growth environment for the aortic aneurysm stent grafts market in the United States as well as the North American region.
To know more about why North America is leading the market growth in the aortic aneurysm stent grafts market, get a snapshot of the Aortic Aneurysm Stent Grafts Market Outlook
Aortic Aneurysm Stent Grafts Market Dynamics
The aortic aneurysm stent grafts market is experiencing increased product demand for a variety of reasons. The key factor is the increasing number of aortic aneurysm cases worldwide, which leads to increased demand for the product, creating growth opportunities for the Global aortic aneurysm stent grafts Market. Several risk factors, such as smoking and alcohol consumption, play an important role in developing aortic aneurysms. Another major factor driving the growth of the aortic aneurysm stent grafts market is the world's growing geriatric population.
However, high treatment costs and perioperative and postoperative complications, such as the risk of stent movement and others, may be limiting factors in the growth of the aortic aneurysm stent grafts market.
Additionally, during the COVID-19 pandemic, the aortic aneurysm stent grafts market was one of the few that experienced positive growth. Because of the growing demand among COVID-19 patients, the impact of the COVID-19 pandemic resulted in a surge in revenue for the aortic aneurysm stent grafts market. As a result, during the COVID-19 pandemic, the aortic aneurysm stent grafts market was expected to grow positively.
Get a sneak peek at the aortic aneurysm stent grafts market dynamics @Aortic Aneurysm Stent Grafts Market Dynamics Analysis
| Report Metrics | Details |
| Coverage | Global |
| Study Period | 2019–2027 |
| Base Year | 2021 |
| Market CAGR | 5.71% |
| Key Aortic Aneurysm Stent Grafts Companies | Medtronic, Terumo, Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (MicroPort Scientific Corporation), Cook, Cordis, JOTEC GmbH, W. L. Gore & Associates, Inc., Endologix LLC, Lombard Medical, Lifetech Scientific, SB-Kawasumi Laboratories, Inc., Endospan, among others |
Aortic Aneurysm Stent Grafts Market Assessment
- Aortic Aneurysm Stent Grafts Market Segmentation
- Market Segmentation By Product: Abdominal Aortic Stent Graft, Thoracic Aortic Stent Graft
- Market Segmentation By End User: Hospitals, Ambulatory Surgical Centers, Others
- Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Which MedTech key players in the aortic aneurysm stent grafts market are set to emerge as the trendsetter explore @Aortic Aneurysm Stent Grafts Companies
Table of Contents
| 1 | Report Introduction |
| 2 | Executive summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Key Factors Analysis |
| 5 | Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Aortic Aneurysm Stent Grafts Market |
| 7 | Aortic Aneurysm Stent Grafts Market Layout |
| 8 | Global Company Share Analysis – Key 3-5 Companies |
| 9 | Aortic Aneurysm Stent Grafts Market Company and Product Profiles |
| 10 | Project Approach |
| 11 | About DelveInsight |
Interested in knowing the aortic aneurysm stent grafts market by 2027? Click to get a snapshot of the Aortic Aneurysm Stent Grafts Market Trends
Related Reports
Abdominal Aortic Aneurysm Market
Abdominal Aortic Aneurysm Market Insight, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key abdominal aortic aneurysm companies, including Endologix LLC, Cardinal Health, Cook Medical, W. L. Gore & Associates, Inc., Medtronic, MicroPort Scientific Corporation, among others.
Abdominal Aortic Aneurysm Epidemiology
Abdominal Aortic Aneurysm Epidemiology Forecast – 2032 report delivers an in-depth understanding of the disease, historical, and forecasted abdominal aortic aneurysm epidemiology in the 7MM.
Abdominal Aortic Aneurysm Pipeline
Abdominal Aortic Aneurysm Pipeline Insight – 2022 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key abdominal aortic aneurysm companies, including Faron Pharmaceuticals, Novartis, AstraZeneca, among others.
Abdominal Aneurysm Pipeline Insight – 2022 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key abdominal aneurysm companies, including Faron Pharmaceuticals, Novartis, AstraZeneca, among others.
Abdominal Aneurysm Epidemiology
Abdominal Aneurysm Epidemiology Forecast – 2032 report delivers an in-depth understanding of the disease, historical, and forecasted abdominal aneurysm epidemiology in the 7MM.
Complicated Intra-Abdominal Infections Market
Complicated Intra-Abdominal Infections Market Insights, Epidemiology, and Market Forecast-2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key complicated intra-abdominal infections companies, including MerLion Pharmaceuticals, AiCuris, Novartis, among others.
Complicated Intra-Abdominal Infections Pipeline
Complicated Intra-Abdominal Infections Pipeline Insight – 2022 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key complicated intra-abdominal infections companies, including Pfizer, Shionogi, Iterum Therapeutics, Nosopharm, among others.
Other Trending Reports
Goitre Market | Thymus Cancer Market | US Healthcare Outlook Report | Venous Stenosis Market | Negative Pressure Wound Therapy Systems Market | Metrorrhagia Market | Dysfunctional Uterine Bleeding Market | Hypereosinophilic Syndrome Market | Age-related Vision Dysfunction Market | Dental Lasers Market | CRISPR Therapies Pipeline Insight | Cell And Gene Therapy For Multiple Myeloma Market | Drug Hypersensitivity Market | Dysthymia Market | Persistent Depressive Disorder Market | Cancer Vaccines Market | Weight Loss/Weight Management (Obesity) Market | Food Allergy Market | Obsessive-Compulsive Disorder Market | Tumor Ablation Market | Physiotherapy Equipment Market | CAR-T Pipeline Insight | Anti-hypertension Market | Radiofrequency Ablation Devices Market | Global Messenger RNA (mRNA)-based Vaccines and Therapeutics Market | Gastro Intestinal Bleeding Market | Trastuzumab Biosimilars Insight | Varicose Veins Market | Germ Cell Tumor Market | Intracardiac Echocardiography Devices Market | India Healthcare Outlook Report | Crows Feet Market Insight | Seborrhoeic Dermatitis Market | Injectable Drug Delivery Devices Market | Structural Heart Devices Market | Substance (Drug) Abuse Market
Related Healthcare Blogs
Upcoming Cardiovascular Diseases Drugs
Key Companies in the Cardiology Segment
Top Cardiac Devices in the Market
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
